Elsevier

Neurobiology of Disease

Volume 2, Issue 1, February 1995, Pages 13-21
Neurobiology of Disease

Regular Article
Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle

https://doi.org/10.1006/nbdi.1995.0002Get rights and content

Abstract

Vascular pathology is an underestimated complication of neurofibromatosis 1 (NF1). Manifestations include renovascular stenosis with associated hypertension, cerebrovascular occlusion, visceral ischaemia and aneurysms of smaller arteries. This is illustrated by a woman recently evaluated in our Neurofibromatosis Program who had multiple cerebrovascular and renovascular abnormalities. To determine the contribution ofNF1expression to NF1 vasculopathy, the expression of theNF1gene product, neurofibromin, was examined in blood vessels. Neurofibromin was detected in the endothelial cell layer of rat cerebral vessels, renal arteries, and aorta by immunohistochemistry. Cultured bovine cerebral endothelial cells were found to expressNF1mRNA by RT-PCR and neurofibromin by Western immunoblotting and immunocytochemistry. Neurofibromin expression was also detected in the smooth muscle layer of the aorta but not of cerebral or renal vessels. The vascular abnormalities of NF1 are reviewed and possible pathogenesis with respect to neurofibromin expression is discussed.

References (0)

Cited by (92)

  • Ischemic stroke with extensive vasculopathy in a patient with neurofibromatosis type 1

    2022, Radiology Case Reports
    Citation Excerpt :

    This case demonstrates widespread vasculopathy associated with NF1 in the form of vertebrobasilar dolichoectasia, right internal carotid pseudoaneurysm formation and acute left internal carotid dissection with tandem occlusion. The likely pathogenesis of NF1-associated vasculopathy is deficiency of neurofibromin, the protein product of the NF1 gene which is important in maintaining integrity of the endothelial cell layer [9]. No specific guidelines for treatment of dolichoectasia exist at present and intervention is limited to symptomatic cases [10,11].

  • Diagnosis of neurofibromatosis type 1 after rupture of aneurysm and consequent fatal hemothorax

    2020, American Journal of Emergency Medicine
    Citation Excerpt :

    Neurofibromatosis type 1 (NF1) is an autosomal dominant genetic disorder with an incidence of approximately 1 in 2600 to 3000 individuals. Approximately half of the cases are inherited [1–17]. NF1 is diagnosed based on the presentation of main clinical features of NF1, for example, multiple café-au-lait macules and neurofibromas.

  • Delayed cerebral vasculopathy following cranial radiation therapy for pediatric tumors

    2014, Pediatric Neurology
    Citation Excerpt :

    A study by Desai et al.52 inferred that NF-1 patients with RT-induced moyamoya have a lower radiation dose threshold (average: 46.5 Gy vs 58.1 Gy), but we found no difference in radiation dose for patients with NF-1 and patients without NF-1 who developed cerebrovasculopathy. Previous studies have demonstrated the association between NF-1 and moyamoya both in patients who have and have not undergone RT.15,52 The tendency of NF-1 patients to develop moyamoya without RT may occur because of neurofibromin that is encoded by the NF-1 gene, which is expressed in vascular endothelial and smooth muscle cells.53 Our literature search identified only 12 cases of moyamoya resulting from cranial irradiation for tumors in NF-1 patients, and so, obtaining firm conclusions regarding a lower radiation dose threshold is difficult.

View all citing articles on Scopus
f1

Correspondence: David H. Gutmann, Washington University School of Medicine, Box 8111, 660 S. Euclid Avenue, St. Louis, MO 63110, USA.

View full text